spacer
home > directory > BioGenes GmbH
PHARMACEUTICAL INDUSTRY DIRECTORY

BioGenes GmbH

BioGenes GmbH, founded in 1992 and based in Berlin, Germany, is a worldwide acting full-service provider of customized antibody and immunoassay development with a strong commitment to quality and service.
The company provides highly customized solutions for quality control of biological products, drug discovery, drug development, manufacturing of biologicals as well as for diagnostic purposes. BioGenes is a recognized partner of biotech and pharmaceutical companies all over the world.

Our Products & Services

Custom Antibody Development (pAbs, mAbs, anti-IDs)

BioGenes offers highly sophisticated custom monoclonal, polyclonal and anti-idiotypic antibody development for use in quality control, biosimilar development, PK studies and immunogenicity assays.

Custom ELISA Development, Qualification and Kit Production

BioGenes has a proven track record in the development, optimization, pre-validation and production of highly sensitive and robust ELISAs. The customer can order single services or full-service packages, and either the manufacturing of assay components or complete kits.

BioGenes specializes in multi-product (platform) and specific host cell protein (HCP) assays. Pre-Validation is carried out according to ICH guidelines. All assays are developed according to the highest quality standards, required by the FDA and EMA.

Analytical Services

BioGenes supports customers with a comprehensive range of analytical services which meet all of their requirements for custom antibody and assay development including: • HCP coverage determination (2D Western Blots)
• 2D analysis of HCP samples
• DIGE analysis of process samples
• Immune affinity chromatography (IAC)

Products

Our scientists have developed the enhanced generic 360-HCP ELISA based on a unique approach that increases the specificity and sensitivity of traditional generic HCP assays. We offer each four types of generic HCP ELISA kits for CHO- and E.coli cell lines including related reagents. For the selection of the most suitable kit for the special process we provide customers with a special “performance study”.

Quality and Regulatory

BioGenes is certified according to ISO 9001 standards since 1999. The company meets the international requirements and regularities of quality assurance and animal welfare and maintains long-term alliances with biotech and pharmaceutical companies as well as research institutes all over the world. The works performed in our labs, especially for industry customers, and the documentation follow certain GMP and GLP guidelines. Assay pre-validation is performed according to ICH guidelines.

Contact: www.biogenes.de, service@biogenes.de, +49 (30) 65762396
phone +49 (0)30 6576 2396
email service@biogenes.de
web www.biogenes.de
email Koepenicker Str. 325 D-12555 Berlin Germany
 
spacer

Member login

E-mail address:

Password:
Remember me

Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement